TVRD Tvardi Therapeutics, Inc.
Company Analysis
Latest News
🟢 Tvardi Therapeutics is trading 5.9% up today after Chardan's Buy initiation and $8.00 target
Tvardi Therapeutics is trading at $1.05, up 5.85%, after Chardan initiated coverage with a Buy rating and an $8.00 price target. - Chardan initiated coverage...
🟢 Tvardi Therapeutics is trading 6.9% up in pre-market after Chardan initiated coverage with a Buy
Tvardi Therapeutics is trading at $1.06, up 6.85%, after Chardan initiated coverage with a Buy rating and an $8.00 price target. - Chardan’s October 20...
🟢 Tvardi Therapeutics is trading 6% up today amid a 2.10% biotech-sector gain
Tvardi Therapeutics is trading at $1.03, up 6.19%, amid broader biotech-sector strength. - The biotech sector is up 2.10%, providing same-direction context. -...
🟢 Tvardi Therapeutics is trading 5% up in pre-market with no clear company-specific catalyst
Tvardi Therapeutics is trading 5.15% up at $1.02, compared with its October 19 close of $0.97; no clear company-specific news explaining the pre-market rise...
🟢 Tvardi Therapeutics is trading 8.9% up in pre-market
Tvardi Therapeutics is trading at $1.10, up 8.91% in pre-market on October 19, 2026; the reason for the move is unclear. - The company’s investor-relations...
🔴 Tvardi Therapeutics is trading 5% down amid biotech weakness and broader risk-off pressure
Tvardi Therapeutics is trading at $1.02, down 5.06%, amid biotech weakness and broader risk-off pressure. - No new company-specific announcement explaining the...
🟢 Tvardi Therapeutics is trading 7% up amid broader biotech gains
Tvardi Therapeutics is trading at $1.07, up 6.99%, amid a rise in biotech shares, though the cause of its gain is unclear. - The company’s October 14...
🔴 Tvardi Therapeutics is trading 5.66% down in pre-market with no clear company-specific catalyst identified
Tvardi Therapeutics is trading at $1.00, down 5.66% in pre-market; no clear company-specific catalyst for the decline was identified. - The company’s latest...
🟢 Tvardi Therapeutics is trading 5.8% up in pre-market with no clear catalyst identified
Tvardi Therapeutics is trading 5.8% up in pre-market at $1.09, versus the $1.03 October 9 close; no clear catalyst has been identified. - The move follows a...
🔴 Tvardi Therapeutics is trading 5% down on October 9 with no clear company-specific catalyst identified
Tvardi Therapeutics is trading at $1.02, down 5.09%, with no clear company-specific catalyst identified during the October 9 session. - The latest listed...
🟢 Tvardi Therapeutics is trading 12.4% up in pre-market
Tvardi Therapeutics is trading 12.39% up at $1.21 in pre-market, with no clear catalyst identified. - The move follows several declining sessions; the October...
🔴 Tvardi Therapeutics is trading 5% down today as biotech falls 2.04%
Tvardi Therapeutics is trading at $1.04, down 5.00%, as broader market and biotech weakness may be weighing on shares. - No October 8 company-specific...
🟢 Tvardi Therapeutics is trading 6.5% up in after-hours trading
Tvardi Therapeutics is trading at $1.15, up 6.48% in after-hours trading; no clear catalyst was identified. - The stock closed at $1.08 on October 6, after...
🔴 Tvardi Therapeutics is trading 5% down amid broader biotechnology weakness
Tvardi Therapeutics is trading 5.26% lower at $1.08, with biotechnology-sector weakness the likeliest explanation; no direct cause for the individual move is...
🟢 Tvardi Therapeutics is trading 6.1% up in pre-market with no clear catalyst identified
Tvardi Therapeutics is trading 6.14% higher at $1.21 in pre-market; no clear company-specific catalyst was identified for the October 6, 2026 move. - The...
🟢 Tvardi Therapeutics is trading 6.1% up in pre-market with no clear company-specific catalyst identified
Tvardi Therapeutics is trading at $1.22, up 6.1%, in pre-market on October 5 versus the supplied previous close of $1.15; no clear company-specific...
🔴 Tvardi Therapeutics is trading 5.7% down — no clear company-specific catalyst identified
Tvardi Therapeutics is trading 5.7% lower at $1.17, with no clear company-specific announcement identified to explain the October 2 move. - The broader market...
🟢 Tvardi Therapeutics is trading 10.5% up in pre-market — catalyst remains unclear
Tvardi Therapeutics is trading at $1.38, up 10.51%, with the October 1 pre-market gain’s cause unclear. - No clear company-specific announcement or catalyst...
🔴 Tvardi Therapeutics is trading 9.7% down in pre-market with no clear company-specific catalyst
Tvardi Therapeutics is trading 9.72% down at $1.13, versus the September 30 close of $1.25; no clear company-specific catalyst was identified for the...
🔴 Tvardi Therapeutics is trading 9.6% down in after-hours trading
Tvardi Therapeutics is trading at $1.13, down 9.60% in after-hours trading, with no clear company-specific catalyst identified. - The regular-session close...